| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ARCLK
|
88.85 | 58.3B | — | 0.75 | 4.74 | 3.5% | 14.7% | 57 | 46 | 142.37 | +38.5% | 26 | 3.32 |
|
VESBE
|
5.45 | 8.7B | — | 0.22 | 8.26 | -2.0% | 21.9% | 47 | 30 | 11.00 | +51.9% | 24 | 0.63 |
|
VESTL
|
24.06 | 8.1B | — | 0.31 | 53.80 | -7.2% | 12.1% | 37 | 23 | 29.96 | +12.5% | 7 | 3.60 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.